← Compounds
N-Acetyl Selank Amidate
peptide · headlineResearch use onlyModulates GABAergic neurotransmission via gene expression and receptor sensitivity
Summary
N-Acetyl Selank Amidate is a nootropic peptide derived from tuftsin and enhanced through N-acetylation for improved stability. It modulates GABA, serotonin, and neurotrophic signaling and has demonstrated powerful anti-anxiety, cognitive-enhancing, and immunomodulatory effects in preclinical and clinical settings. Its intranasal use enables fast CNS action with a high safety margin. It has been investigated in Russian research for immune modulation and neurochemical balance.
How it works
- Modulates GABAergic neurotransmission via gene expression and receptor sensitivity
- Influences serotonin and dopamine balance through neuropeptide regulation
- Upregulates BDNF expression and neuroplasticity markers
- Reduces pro-inflammatory cytokines in brain and periphery
- Enhances adaptive stress response and immune homeostasis
Dosing
- unit: mcglow dose: 200frequency: 1–3x dailyhigh dose: 500standard dose: 300administration route: Intranasal
Cycling
- Use 1–3x per day for 10–14 days. Repeat cycles monthly as needed for mood, anxiety, or performance support.
Side effects
long term: ["Limited long-term human data on N-Acetyl Selank specifically; safety extrapolated from Selank clinical use"]
Chemistry & PK
sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
half life: Likely short (5–15 minutes in plasma); longer CNS effects due to gene expression changes
degradation: Cleared by tissue peptidases
molecular weight: 751.89
molecular formula: C33H57N11O9
tissue specificity: CNS regions regulating anxiety, stress, and learning (amygdala, hippocampus, cortex)
Verified citations
3 · PubMed-checked- Functional Connectomic Approach to Studying Selank and Semax Effects.clinicalPMID 32342318 ↗
- Selank Attenuates Aversive Signs of Morphine Withdrawal in Rats.preclinicalPMID 36322304 ↗
- Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety.preclinicalPMID 28280289 ↗
Legal / compounding
Research use only
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.